As summarized in our work by bioinformatics analysis and in vitro experiment, we provided the evidence that TYMS is abnormally expressed in metastatic HCC, TYMS can be used as an indicator for risk stratification that helps to predict the prognosis of HCC. Here, TYMS is linked to hepatocellular carcinoma.